Guillain–Barré Syndrome Warning to be Added to Johnson & Johnson COVID-19 Vaccine
The FDA has added new label warnings to the Johnson & Johnson COVID-19 vaccine, indicating it may increase the risk of an autoimmune disorder known as Guillain–Barré syndrome.